Faculty Disclosures
| Richard J. Caselli, MD, FAAN |
The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona. |
| Kenneth M. Heilman, MD, FAAN |
Dr. Heilman has received publishing royalties from a publication relating to health care. |
| Leon J. Thal, MD |
No disclosure on file
|
| John M. Stern, MD, FAAN |
Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. |
| Maria Eriksdotter-Jonhagen |
No disclosure on file
|
| Daniel Kantor, MD, FAAN |
Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas, LLC. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica Pharmaceuticals. The institution of Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Kantor has received research support from Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities. |
| Aiesha Ahmed, MD, MBA, FAAN |
Dr. Ahmed has stock in Doximity. |
| Zulfi Haneef, MD, MBBS, MRCP, FAAN |
Dr. Haneef has nothing to disclose. |
|
No disclosure on file
|
| Alicia S. Parker, MD |
An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care. |
| Ashok K. Kayal, MD |
No disclosure on file
|
| Roy A. Poblete, MD |
No disclosure on file
|
| Sandhya Ravikumar, MD |
Dr. Ravikumar has nothing to disclose. |
| Venkat Raghav Aachi, MD |
No disclosure on file
|
| Omar M. Hussein, MD |
No disclosure on file
|
| Sharon Chiang, MD, PhD |
Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 . |
| William K. Jens, DO, FAAN |
Dr. Jens has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abvie. |
| Munindra Goswami, MD |
No disclosure on file
|
| Hooman H. Beygi |
No disclosure on file
|
| Fareed Khan, MBBS |
No disclosure on file
|
| Leila Saadatpour, MD |
Dr. Saadatpour has nothing to disclose. |
| Usama Tariq, MD |
Dr. Tariq has nothing to disclose. |